Collaboration to chart AI-generated map of the immune system
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
The pharma firm will lend support to Aqemia’s high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.
An executive from the digital biomarker tech company explains the myriad benefits of biomarker analysis in advancing precision health solutions.